NCT00081744已完成3 期
A Multicenter, Double-Blind, Randomized Comparison Study Of the Efficacy and Safety of Tigecycline to Imipenem/ Cilastatin to Treat Complicated Intra-Abdominal Infections in Hospitalized Subjects
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 850 人开始时间: 2002年11月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 850
研究概览
简要总结
Purpose: To provide a mechanism for the emergency use of tigecycline in the appropriate clinical situations.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 8 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female subjects, ≥ 8 years of age and a weight of ≥ 35 kilograms
- •Subjects with selected culture-positive infections caused by a multiple antibiotic-resistant pathogen presumed to be susceptible to tigecycline
- •Subjects who have failed or are intolerant of other available appropriate antibiotic therapies or whose pathogens are resistant to other available antibiotics
排除标准
- •Subjects who are moribund with an expected survival of less than 2 weeks.
- •Subjects who have been designated as "Do Not Resuscitate", unless it is anticipated within a reasonable degree of medical certainty that they can achieve benefit from potentially curative antibiotic therapy
- •Known or suspected hypersensitivity to tigecycline, tetracyclines, or other compounds related to this class of antibacterial agents
研究者
相似试验
已完成
3 期
Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens.Bacterial InfectionsNCT00205816Wyeth is now a wholly owned subsidiary of Pfizer26
撤回
3 期
Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired PneumoniaCommunity Acquired Bacterial PneumoniaComplicated Intra-Abdominal InfectionNCT01602874Pfizer
撤回
3 期
Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired PneumoniaCommunity Acquired Bacterial PneumoniaComplicated Intra-Abdominal InfectionNCT00914888Wyeth is now a wholly owned subsidiary of Pfizer
撤回
3 期
Study Evaluating Tigecycline Versus Clindamycin Or Vancomycin On Complicated Skin And Skin Structure Infections Including Those Due To Methicillin-Resistant Staphylococcus Aureus (MRSA) In Pediatric SubjectsSkin DiseasesInfectionNCT00911573Wyeth is now a wholly owned subsidiary of Pfizer
终止
2 期
Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired PneumoniaPneumonia, BacterialNCT00707239Pfizer108